文献速递关节外科创伤骨科

髋关节假体周围感染一期翻修术后再翻修的相关因素有哪些?病例对照研究

What are the Factors Associated with Re-revision After One-stage Revision for Periprosthetic Joint Infection of the Hip? A Case-control Study.
PubMed 文献 · Clin Orthop Relat Res · 2019-01-01

该单中心回顾性病例对照研究分析了2009至2017年因髋关节假体周围感染行一期翻修术后再翻修的患者121例,并与年龄、性别和一期翻修年份1:1匹配的对照组比较,发现持续伤口引流至少1周、分离出肠球菌及一期翻修前因感染手术史与再翻修风险增加独立相关。

要点

  • 持续伤口引流至少1周与再翻修风险增加独立相关(OR 7.4;95%CI 2.6-20.6;p<0.001)。
  • 分离出肠球菌与再翻修风险增加独立相关(OR 4.8;95%CI 1.4-15.7;p=0.010)。
  • 一期翻修前因感染手术史与再翻修风险增加独立相关(OR 3.6;95%CI 2.0-6.4;p<0.001)。

核心结论

  • 一期翻修术后持续伤口引流必须严格处理;有髋关节感染手术史的患者在决定一期翻修时应被告知再翻修风险;分离出肠球菌时术者可考虑其他治疗方式而非一期翻修;作者建议行一期翻修髋关节置换时使用双动杯以降低脱位风险。

研究设计与样本

  • 单中心回顾性病例对照分析,纳入2009至2017年因髋关节假体周围感染行一期翻修术后因任何原因(包括再感染)再翻修的患者121例,并与按年龄、性别和一期翻修年份1:1匹配的对照者比较。

主要发现

  • 再翻修手术平均在407天后进行;再翻修的主要原因包括反复髋关节脱位53/121例(44%)、再感染(包括新发和持续感染)40/121例(33%)和无菌性松动16例(13%);再翻修术后另有43/121例(36%)接受了再次翻修手术。
  • 再翻修组平均住院时间26天(SD 11.6天),对照组22天(SD 6.6天);对照组平均随访66个月(范围17-119个月)。
  • 与任何原因再翻修独立相关的因素为持续伤口引流至少1周(OR 7.4;95%CI 2.6-20.6;p<0.001)、分离出肠球菌(OR 4.8;95%CI 1.4-15.7;p=0.010)和一期髋翻修前因感染手术史(OR 3.6;95%CI 2.0-6.4;p<0.001)。
  • 与再感染(包括新发和持续感染)相关的因素为延长伤口引流(OR 6.9;95%CI 2.2-21.5;p=0.001)和因感染手术史(OR 4.3;95%CI 1.9-9.5;p<0.001)。

临床怎么用

  • 作者认为一期翻修术后持续伤口引流必须严格处理。
  • 作者认为有髋关节感染手术史的患者在决定一期翻修时应被告知再翻修风险。
  • 作者认为分离出肠球菌时术者可考虑其他治疗方式而非一期翻修。
  • 作者建议行一期翻修髋关节置换时使用双动杯以降低脱位风险。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite increased interest in one-stage revision arthroplasty for periprosthetic joint infection (PJI) of the hip, the reported infection-free proportions after the one-stage approach are still comparable to that of two-stage revision. However, we still lack studies that analyze factors associated with any re-revision after one-stage revision arthroplasty for PJI. QUESTIONS/PURPOSES: After one-stage revision arthroplasty for PJI of the hip, what factors were associated with an increased risk of re-revision, and what factors were associated with an increased risk of reinfection? METHODS: We performed a single-center retrospective case-control analysis. Patients who underwent one-stage revision arthroplasty for PJI of the hip in our hospital between 2009 and 2017, and who were subsequently re-revised due to any reason, including reinfection, were identified from our electronic medical records. A total of 121 patients who underwent repeat revision for any reason after one-stage exchange for PJI of the hip were identified. The re-revision procedures were performed after a mean of 407 days. The primary reasons for re-revision were repeated hip dislocation in 53 of 121 patients (44%), reinfection including both new and persistent infections in 40 of 121 patients (33%), and aseptic loosening in 16 patients (13%). Forty-three patients underwent another revision procedure after the re-revision procedure (43 of 121; 36%). More than 40 potential patient-, joint- and surgery-related risk factors were investigated and compared with a 1:1 matched control participants by age, sex and year of the one-stage revision. Similar to the re-revision patients, controls were treated for PJI with one-stage revision arthroplasty; however, they did not undergo subsequent revision for any reason by the latest followup examination. The mean followup of the control group was 66 months (range, 17-119 months). The mean length of hospital stay was 26 days in the re-revised group (SD, 11.6 days) compared with 22 days for the controls (SD, 6.6 days). All analyses were performed to identify factors associated with general re-revision and reinfection. RESULTS: The independent factors associated with repeat revision for any reason were persistent wound drainage for at least 1 week (odds ratio [OR], 7.4; 95% CI, 2.6-20.6; p < 0.001), isolation of enterococci (OR, 4.8; 95% CI, 1.4-15.7; p = 0.010), and prior surgery due to infection before the one-stage hip revision (OR, 3.6; 95% CI, 2.0-6.4; p < 0.001). The factors associated with reinfection including both new and persistent infections were prolonged wound drainage (OR, 6.9; 95% CI, 2.2-21.5; p = 0.001) and prior surgery due to infection (OR, 4.3; 95% CI, 1.9-9.5; p < 0.001). CONCLUSIONS: Prolonged wound drainage after the one-stage revision arthroplasty for PJI of the hip must be treated rigorously. Patients with a history of a prior surgical procedure due to hip infection should be informed about the risk of further re-revision when deciding for the one-stage exchange. In case of enterococcal isolation, surgeons may consider another treatment approach rather than the one-stage exchange. Furthermore, we recommend the use of dual mobility cups when performing the one-stage revision hip arthroplasty to reduce the risk of dislocation.Level of Evidence Level III, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Abdelaziz H, Grüber H, Gehrke T, et al. What are the Factors Associated with Re-revision After One-stage Revision for Periprosthetic Joint Infection of the Hip? A Case-control Study. Clin Orthop Relat Res. 2019. PMID: 31135547. doi:10.1097/CORR.0000000000000780

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。